Methotrexate use in rheumatoid arthritis. A clinician's perspective

Immunopharmacology

Volumn 47, Issue 2-3, 2000, Pages 259-271

  Alarcón, Graciela S ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Methotrexate; Rheumatoid arthritis; Treatment

Indexed keywords

METHOTREXATE;

CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG MECHANISM; DRUG SAFETY; DRUG USE; HUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RHEUMATOLOGY;

EID: 0034081846     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(00)00184-3     Document Type: Article

References (170)

1. Abu-Shakra M., Gladman D.D., Thorne J.C., Long J., Gough J., Farewell V.T. Long term methotrexate therapy in psoriatic arthritis: clinical and radiological outcome. J. Rheumatol. 22:1995;241-245.
2. Abu-Shakra M., Nicol P., Urowitz M.B. Accelerated nodulosis, pleural effusion, and pericardial tamponade during methotrexate therapy. J. Rheumatol. 21:1994;934-937.
3. Aglas R., Rainer F., Hermann J., Gretler J., Huttl E., Domej W., Krejs G.J. Interstitial pneumonia due to cytomegalovirus following low-dose methotrexate treatment for rheumatoid arthritis. Arthritis Rheum. 38:1995;291-292.
4. Ahern M.J., Kevat S., Hill W., Hayball P.J., Harley H., Hall P. Hepatic methotrexate content and progression of hepatic fibrosis: preliminary findings. Ann. Int. Med. 50:1991;477-480.
5. Al-Awadhi A., Dale P., McKendry R.J.R. Pancytopenia associated with low dose methotrexate therapy. J. Rheumatol. 20:1993;1121-1124.
6. Alarcón G.S. Methotrexate: its use for the treatment of rheumatoid arthritis and other rheumatic disorders. Koopman W.J. Arthritis and Allied Conditions. A Textbook of Rheumatology. 1997;679-698 Williams and Wilkins, Baltimore.
7. Alarcón G.S., Kremer J.M., Macaluso M., Weinblatt M.E., Cannon G.W., Palmer W.R., St Clair E.W., Sundy J.S., Alexander R.W., Smith G.J., Axiotis C.A. Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group. Ann. Intern. Med. 127:1997;356-364.
8. Alarcón G.S., López-Méndez A., Walter J., Boerbooms A.M.T., Russell A.S., Furst D.E., Rau R., Drosos A.A., Bartolucci A.A. Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis. J. Rheumatol. 19:1992;1868-1873.
9. Alarcón G.S., Tracy I.C., Blackburn W.D.J. Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum. 32:1989;671-676.
10. Alarcón G.S., Tracy I.C., Strand G.M., Singh K., Macaluso M. Survival and drug discontinuation analyses in a large cohort of methotrexate-treated rheumatoid arthritis patients. Ann. Rheum. Dis. 54:1995;708-712.
11. Altz-Smith M., Kendall L.G.J., Stamm A.M. Cryptococcosis associated with low-dose methotrexate for arthritis. Am. J. Med. 83:1987;179-181.
12. Guidelines for monitoring drug therapy in rheumatoid arthritis. Arthritis Rheum. 39:1996;723-731.
13. Anaya J., Diethelm L., Ortiz L.A., Gutierrez M., Citera G., Welsh R.A., Espinoza L.R. Pulmonary involvement in rheumatoid arthritis. Sem. Arthritis Rheum. 24:1995;242-254.
14. Aponte J., Petrelli M. Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate. Arthritis Rheum. 31:1988;1457-1464.
15. Arias J.M., Morton K.A., Albro J.E., Patch G.G., Valdivia S., Greenberg H.E., Christian P.E., Datz F.L. Comparison of methods for identifying early methotrexate-induced hepatotoxicity in patients with rheumatoid arthritis. J. Nucl. Med. 34:1993;1905-1909.
16. Aspe de la Iglesia B., Sanchez-Burson J., Grana-Gil J., Galdo-Fernandez F. Pancitopenia e infecciones oportunistas en artritis reumatoid tratada con metotrexato. Pancytopenia and opportunistic infections in rheumatoid arthritis treated with methotrexate Rev. Clin. Espanol. 187:1990;208-209.
17. Bachman T.R., Sawitzke A.D., Perkins S.L., Ward J.H., Cannon G.W. Reversible lymphoma in rheumatoid arthitis patients treated with methotrexate: report of two cases. Arthritis Rheum. 39:1996;325-329.
18. Baggott J.E., Morgan S.L., Ha T., Alarcón G.S., Koopman W.J., Krumdieck C.L. Antifolates in rheumatoid arthritis: a hypothetical mechanism of action. Clin. Exp. Rheumatol. 11:1993;S101-S105.
19. Bannwarth B., Vernhes J., Schaeverbeke T., Dehais J. The facts about methotrexate in rheumatoid arthritis. Rev. Rheum. 62:1995;471-473.
20. Basin K.S., Escalante A., Beardmore T.D. Severe pancytopenia in a patient taking low dose methotrexate and probenecid. J. Rheumatol. 18:1991;608-610.
21. Bergquist S.R., Felson D.T., Prashker M.J., Freedberg K.A. The cost-effectiveness of liver biopsy in rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum. 38:1995;326-333.
22. Berthelot J., Maugars Y., Hamidou M., Chiffoleau A., Barrier J., Gorolleau J., Prost A. Pancytopenia and severe cytopenia induced by low-dose methotrexate. Eight case-reports and a review of one hundred cases from the literature (with twenty-four deaths). Rev. Rheum. 62:1995;477-486.
23. Bjorkman D.J., Boschert M., Tolman K.G., Clegg D.O., Ward J.R. The effect of long-term methotrexate therapy on hepatic fibrosis in rheumatoid arthritis. Arthritis Rheum. 36:1993;1691-1696.
24. Bjorkman D.J., Hammond E.H., Lee R.G., Clegg D.O., Tolman K.G. Hepatic ultrastructure after methotrexate therapy for rheumatoid arthritis. Arthritis Rheum. 31:1988;1465-1472.
25. Blackburn W.D.J., Alarcón G.S. Impotence in three rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum. 32:1989;1341-1342.
26. Boerbooms A.M., Kerstens P.J., van Loenhout J.W., Mulder J., van de Putte L.B. Infections during low-dose methotrexate treatment in rheumatoid arthritis. Sem. Arthritis Rheum. 24:1995;411-421.
27. Bologna C., Jorgensen C., Sany J. Methotrexate as the initial second-line disease modifying agent in the treatment of rheumatoid arthritis patients. Clin. Exp. Rheumatol. 15:1997;597-601.
28. Bologna C., Viu P., Picot M.C., Jorgensen C., Sany J. Long-term follow-up of 453 rheumatoid arthritis patients treated with methotrexate an open, retrospective, observational study. Br. J. Rheumatol. 36:1997;535-540.
29. Bridges S.L.J., Alarcón G.S., Koopman W.J. Methotrexate-induced liver abnormalities in rheumatoid arthritis. J. Rheumatol. 16:1989;1180-1183.
30. Bridges S.L.J., López-Méndez A., Han K.H., Tracy I.C., Alarcón G.S. Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis? J. Rheumatol. 18:1991;984-988.
31. Bridges S.L. Jr., Moreland L.W. Perioperative use of methotrexate in patients with rheumatoid arthritis undergoing orthopedic surgery. Rheum. Dis. Clin. N. Am. 23:1997;981-993.
32. Brown M.A., Corrigan A.B. Pancytopenia after accidental overdose of methotrexate. A complication of low-dose therapy for rheumatoid arthritis. Med. J. Aust. 155:1991;493-494.
33. Bruyn G.A., Essed C.E., Houtman P.M., Willemse F.W. Fatal cardiac nodules in a patient with rheumatoid arthritis treated with low dose methotrexate. J. Rheumatol. 20:1993;912-914.
34. Buchbinder R., Hall S., Sambrook P.N., Champion G.D., Harkness A., Lewis D., Littlejohn G.O., Miller M.H., Ryan P.F.J. Methotrexate therapy in rheumatoid arthritis: a life table review of 587 patients treated in community practice. J. Rheumatol. 20:1993;639-644.
35. Buckley L.M., Bullaboy C.A., Leichtman L., Marquez M. Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum. 40:1997;971-973.
36. Buckley L.M., Leib E.S., Cartularo K.S., Vacek P.M., Cooper S.M. Effect of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis. J. Rheumatol. 24:1997;1489-1494.
37. Carpenter M.T., West S.G., Vogelgesang S.A., Jones D.E.C. Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy. Orthopedics. 19:1996;207-210.
38. Carroll G.J., Thomas R., Phatouros C.C., Atchison M.H., Leslie A.L., Cook N.J., D'Souza I. Incidence, prevalence and possible risk factors for pneumonitis in patients with rheumatoid arthritis receiving methotrexate. J. Rheumatol. 21:1994;51-54.
39. Cash J.M., Swain M., Di Bisceglie M., Wilder R.L., Crofford L.J. Massive intrahepatic hemorrhage following routine liver biopsy in a patient with rheumatoid arthritis treated with methotrexate. J. Rheumatol. 19:1992;1466-1468.
40. Casserly C.M., Stange K.C., Chren M.M. Severe megaloblastic anemia in a patient receiving low-dose methotrexate for psoriasis. J. Am. Acad. Dermatol. 29:1993;477-480.
41. Ching D.W. Severe, disseminated, life threatening herpes zoster infection in a patient with rheumatoid arthritis treated with methotrexate. Ann. Rheum. Dis. 54:1995;155.
42. Clegg D.O., Furst D.E., Tolman K.G., Pogue R. Acute, reversible hepatic failure associated with methotrexate treatment of rheumatoid arthritis. J. Rheumatol. 16:1989;1123-1126.
43. Combe B., Didry C., Gutierrez M., Anaya J.M., Sany J. Accelerated nodulosis and systemic manifestations during methotrexate therapy for rheumatoid arthritis. Eur. J. Med. 2:1993;153-156.
44. Cornelissen J.J., Bakker L.J., Van der Veen M.J., Rozenberg-Arska M., Bijlsma J.W. Nocardia asteroides pneumonia complicating low dose methotrexate treatment of refractory rheumatoid arthritis. Ann. Rheum. Dis. 50:1991;642-644.
45. Creemers M.C.W., Franssen J.A.M., van de Putte L.B.A., Gribnau F.W.J., van Riel P.L.C.M. Methotrexate in severe ankylosing spondylitis: an open study. J. Rheumatol. 22:1995;1104-1107.
46. Cron R.Q., Sherry D.D., Wallace C.A. Methotrexate-induced hypersensitivity pneumonitis in a child with juvenile rheumatoid arthritis. J. Pediatrics. 132:1998;901-902.
47. Dahl M.G.C., Gregory M.M., Scheuer P.J. Methotrexate hepatotoxicity in psoriasis-comparison of different dose regimens. Br. Med. J. 1:1972;654-656.
48. Davidson J.R., Graziano F.M., Rothenberg R.J. Methotrexate therapy for severe systemic lupus erythematosus. Arthritis Rheum. 30:1987;1195-1196.
49. De La Mata J., Blanco F.J., Gomez-Reino J.J. Survival analysis of disease modifying antirheumatic drugs in Spanish rheumatoid arthritis patients. Ann. Rheum. Dis. 54:1995;881-885.
50. Del Paine D.W., Leek J.C., Robbins D.L. Gynecomastia associated with low dose methotrexate therapy. Arthritis Rheum. 1980;691-692.
51. Ellman M.H., Hurwitz H., Thomas C., Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J. Rheumatol. 18:1991;1741-1743.
52. Erickson A.R., Reddy V., Vogelgesang S.A., West S.G. Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients. Arthritis Rheum. 38:1995;1115-1119.
53. Feagan B.G., Rochon J., Fedorak R.N., Irvine E.J., Wild G., Sutherland L., Steinhart H., Greenberg G.R., Gillies R., Hopkins M., Hanauer S.B., McDonald J.W.D., for t.N. Methotrexate for the treatment of Crohn's disease. N. Engl. J. Med. 332:1995;292-297.
54. Felson D.T., Anderson J.J., Meenan R.F. Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials. Arthritis Rheum. 35:1992;1117-1125.
55. Flipo R.M., Delaporte E., Lecomte-Houcke M. Cutaneous pseudolymphoma occurring during methotrexate therapy for rheumatoid arthritis [letter]. J. Rheumatol. 24:1997;809-810.
56. Flood D.A., Chan C.K., Pruzanski W. Pneumocystis carinii pneumonia associated with methotrexate therapy in rheumatoid arthritis. J. Rheumatol. 18:1991;1254-1256.
57. Franck H., Rau R., Herborn G. Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate. Clin. Rheumatol. 15:1996;266-270.
58. Georgescu L., Quinn G.C., Schwartzman S., Paget S.A. Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment. Sem. Arthritis Rheum. 26:1997;794-804.
59. Giannini E.H., Brewer E.J., Kuzmina N., Shaikov A., Maximov A., Vorontsov I., Fink C.W., Newman A.J., Cassidy J.T., Zemel L.S. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. N. Engl. J. Med. 326:1992;1043-1049.
60. Gispen J.G., Alarcón G.S., Johnson J.J., Acton R.T., Barger B.O., Koopman W.J. Toxicity to methotrexate in rheumatoid arthritis. J. Rheumatol. 14:1987;74-79.
61. Golden H.E. Herpes zoster encephalomyelitis in a patient with rheumatoid arthritis treated with low dose methotrexate. J. Rheumatol. 24:1998;2487-2488.
62. Graham L.D., Myones B.L., Rivas-Chacon R.F., Pachman L.M. Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis. J. Pediatrics. 120:1992;468-473.
63. Groenendal H., Rampen F.H. Methotrexate and trimethoprim-sulphamethoxazole - a potentially hazardous combination. Clin. Exp. Dermatol. 15:1990;358-360.
64. Gutierrez-Ureña S., Molina J.F., García C.O., Cuéllar M.L., Espinoza L.R. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. Arthritis Rheum. 39:1996;272-276.
65. Hakim N.S., Kobienia B., Benedetti E., Bloomer J., Payne W.D. Methotrexate-induced hepatic necrosis requiring liver transplantation in a patient with rheumatoid arthritis. Int. Surg. 83:1998;224-225.
66. Halla J.T., Hardin J.G. Underrecognized postdosing reactions to methotrexate in patients with rheumatoid arthritis. J. Rheumatol. 21:1994;1224-1226.
67. Hashkes P.J., Balisteri W.R., Bove K.E., Ballard E.T., Passo M.H. The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis. J. Pediatrics. 134:1999;47-52.
68. Hernandez-Cruz B., Cardiel M.H., Villa A.R., Alcocer-Varela J. Development, recurrence, and severity of infections in Mexican patients with rheumatoid arthritis. A nested case-control study. J. Rheumatol. 25:1998;1900-1907.
69. Hilsden R.J., Urbanski S.J., Swain M.G. End-stage liver disease developing with the use of methotrexate in heterozygous α1-antitrypsin deficiency. Arthritis Rheum. 38:1995;1014-1018.
70. Hoffman G.S., Leavitt R.Y., Kerr G.S., Rottem M., Sneller M.C., Fauci A.S. Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum. 37:1994;578-582.
71. Jeurissen M.E.C., Boerbooms A.M.T., van de Putte L.B.A. Eruption of nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis. Clin. Rheumatol. 8:1989;417-418.
72. Kamel O.W., van de Rijn M., LeBrun D.P., Weiss L.M., Warnke R.A., Dorfman R.F. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Human Pathol. 25:1994;638-643.
73. Karam N.E., Roger L., Hankins L.L., Reveille J.D. Rheumatoid nodulosis of the meninges. J. Rheumatol. 21:1994;1960-1963.
74. Kevat S.G., Hill W.R., McCarthy P.J., Ahern M.J. Pancytopenia induced by low-dose methotrexate for rheumatoid arthritis. Aust. N. Z. J. Med. 18:1988;697-700.
75. Knox T.A., Kaplan M.M., Gelfand J.A., Wolff S.M. Methotrexate treatment of idiopathic granulomatous hepatitis. Ann. Int. Med. 122:1995;592-595.
76. Kozarek R.A., Patterson D.J., Gelfand M.D., Botoman V.A. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann. Int. Med. 110:1989;353-356.
77. Kozlowski R.D., Steinbrunner J.V., Mackenzie A.H., Clough J.D., Wilke W.S., Segal A.M. Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am. J. Med. 88:1990;589-592.
78. Krall P.L., Mazanec D.J., Wilke W.S. Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant cell arteritis. Cleveland Clin. J. Med. 56:1989;253-257.
79. Kremer J.M. Safety, efficacy, and mortality in a long-term cohort of patients with rheumatoid arthritis taking methotrexate: followup after a mean of 13.3 years. Arthritis Rheum. 40:1997;984-985.
80. Kremer J.M., Alarcón G.S., Kaymakcian M., Macaluso M., Weinblatt M.E., Cannon G.W., Palmer W.R., Sundy J.S., Golden H.F., Alexander R.W., Smith G.J.W., Axiotis C.A. Clinical, laboratory and radiographic features of methotrexate lung injury in patients with rheumatoid arthritis: a multicenter study with literature review. Arthritis Rheum. 40:1997;1829-1837.
81. Kremer J.M., Alarcón G.S., Lightfoot R.W., Willkens R.F., Furst D.E., Williams H.J. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. Arthritis Rheum. 37:1994;316-328.
82. Kremer J.M., Furst D.E., Weinblatt M.E., Blotner S.D. Significant changes in serum AST across hepatic histological biopsy grades: prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis. J. Rheumatol. 23:1996;459-460.
83. Kremer J.M., Kaye G.I., Kaye N.W., Kamal I.G., Axiotis C.A. Light and electron microscopic analysis of sequential liver biopsy samples for rheumatoid arthritis patients receiving long-term methotrexate therapy: followup over long treatment intervals and correlation with clinical and laboratory variables. Arthritis Rheum. 38:1995;1194-1203.
84. Kremer J.M., Phelps C.T. Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months. Arthritis Rheum. 35:1992;138-145.
85. Kujala G.A., Shamma'A J.M., Chang W.L., Brick J.E. Hepatitis with bridging fibrosis and reversible hepatic insufficiency in a woman with rheumatoid arthritis taking methotrexate. Arthritis Rheum. 33:1990;1037-1041.
86. Lang B., Riegel W., Peters T., Peter H.H. Low dose methotrexate therapy for rheumatoid arthritis complicated by pancytopenia and pneumocystis carinii pneumonia. J. Rheumatol. 18:1991;1257-1259.
87. Laroche F., Perrot S., Menkes C.J. Pancytopenies au cours de la polyarthrite rhumatoide traitee par methotrexate. Pancytopenia in rheumatoid arthritis treated with methotrexate Presse Medicale. 25:1996;1144-1146.
88. Law K.F., Aranda C.P., Smith R.L., Berkwoitz K.A., Ittman M.M., Lewis M.L. Pulmonary cryptococcosis mimicking methotrexate pneumonitis. J. Rheumatol. 20:1993;872-873.
89. Le Goff P., Koreichi A., Saraux A., Baron A. Lymphome au cours du traitement de la polyarthrite rhumatoide par le methotrexate a faible dose: un nouveau cas. Lymphoma during treatment of rheumatoid arthritis with low-dose methotrexate: a new case Rev. Rheum. 61:1994;357-358.
90. LeMense G.P., Sahn S.A. Opportunistic infection during treatment with low dose methotrexate. Am. J. Respir. Crit. Care Med. 150:1994;258-260.
91. Leonard P.A., Clegg D.O., Carson C.C., Cannon G.W., Egger M.J., Ward J.R. Low dose pulse methotrexate in rheumatoid arthritis: an 8-year experience with hepatotoxicity. Clin. Rheumatol. 6:1987;575-582.
92. Lioté F., Pertuiset E., Cochand-Priollet B., D'Agay M., Dombret H., Numéric P., D'Anglejan G., Kuntz D. Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection. J. Rheumatol. 22:1995;1174-1178.
93. Lomaestro B.M., Lesar T.S., Hager T.P. Errors in prescribing methotrexate. J. Am. Med. Asso. 268:1992;2031-2032.
94. Lower E.E., Baughman R.P. The use of low dose methotrexate in refractory sarcoidosis. Am. J. Med. Sci. 299:1990;153-157.
95. López-Méndez A., Daniel W.W., Reading J.C., Ward J.R., Alarcón G.S. Radiographic assessment of disease progression in rheumatoid arthritis patients enrolled in the Cooperative Systemic Studies of the Rheumatic Diseases Program randomized clinical trial of methotrexate, auranofin, or a combination of the two. Arthritis Rheum. 36:1993;1364-1369.
96. Lyon C.C., Thompson D. Herpes zoster encephalomyelitis associated with low dose methotrexate for rheumatoid arthritis. J. Rheumatol. 24:1997;589-591.
97. Mackinnon S.K., Starkebaum G., Willkens R.F. Pancytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis. Sem. Arthritis Rheum. 15:1985;119-126.
98. Maenaut K., Westhovens R., Dequeker J. Methotrexate osteopathy, does it exist? J. Rheumatol. 23:1996;2156.
99. Maetzel A., Bombardier C., Strand V., Tugwell P., Wells G. How Canadian and US rheumatologists treat moderate or agressive rheumatoid arthritis: a survey. J. Rheumatol. 25:1998;2331-2338.
100. Maricic M., Davis M., Gall E.P. Megaloblastic pancytopenia in a patient receiving concurrent methotrexate and trimethoprim-sulfamethoxazole treatment. Arthritis Rheum. 29:1986;133-135.
101. Marlier S., Chagnon A., Brocq O., de Jaureguiberry J.P., Jaubert D., Paris J.F., Carli P. Lymphome sous methotrexate a faibles doses au cours d'une polyarthrite rheumatoide avec lymphopenie extreme. Lymphoma induced by low-dose methotrexate in rheumatoid arthritis with severe lymphopenia Ann. Med. Int. 146:1995;206-208.
102. Marquez-Neto J.F., Goncalves H.T., Langer L.F.O.B. Prevalence of rheumatoid arthritis in Brazil: a multicenter study. Rev. Espan. Reumatol. 20:1993;152.
103. Mayall B., Poggi G., Parkin J.D. Neutropenia due to low-dose methotrexate therapy for psoriasis and rheumatoid arthritis may be fatal. Med. J. Aust. 155:1991;480-484.
104. McCambridge N.M., Vogelgesang S.A., Ockenhouse C.F. Listeria monocytogenes infection in a patient treated with methotrexate for rheumatoid arthritis. J. Rheumatol. 22:1995;786-787.
105. McKendry R.J.R. The remarkable spectrum of methotrexate toxicities. Rheum. Dis. Clin. N. Am. 23:1997;939-955.
106. McKendry R.J.R., Dale P. Adverse effects of low dose methotrexate therapy in rheumatoid arthritis. J. Rheumatol. 20:1993;1850-1856.
107. Minocha A., Dean H.A., Pittsley R.A. Liver cirrhosis in rheumatoid arthritis patients treated with long-term methotrexate. Vet. Human Toxicol. 35:1993;45-48.
108. Moder K.G., Tefferi A., Cohen M.D., Menke D.M., Luthra H.S. Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study. Am. J. Med. 99:1995;276-281.
109. Moreland L.W., Fleischmann R.M., Strand V. Efficacy of leflunomide vs. placebo vs. methotrexate in early and late rheumatoid arthritis. Arthritis Rheum. 41:1998;S155.
110. Morgan S.L., Baggott J.E., Alarcón G.S. Methotrexate in rheumatoid arthritis. Folate supplementation should always be given. BioDrugs. 8:1997;164-175.
111. Morgan S.L., Baggott J.E., Jeannette Y.L., Alarcón G.S. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention. J. Rheumatol. 25:1998;441-446.
112. Morgan S.L., Baggott J.E., Vaughn W.H., Austin J.S., Veitch T.A., Lee J.Y., Koopman W.J., Krumdieck C.L., Alarcón G.S. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial. Ann. Int. Med. 121:1994;833-841.
113. Morgan S.L., Baggott J.E., Vaughn W.H., Young P.K., Austin J.V., Krumdieck C.L., Alarcón G.S., Koopman W.J. The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum. 33:1990;9-18.
114. Morris C.R., Morris A.J. Localized lymphoma in a patient with rheumatoid arthritis treated with parenteral methotrexate. J. Rheumatol. 20:1993;2172-2173.
115. Mullarkey M.F., Blumenstein B.A., Andrade P., Bailey G.A., Olason I., Wetzel C.E., Pharm B. Methotrexate in the treatment of corticosteroid-dependent asthma. N. Engl. J. Med. 318:1988;603-607.
116. Myllykangas-Luosujärvi R., Aho K., Isomäki H. Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died. J. Rheumatol. 22:1995;2214-2217.
117. Nesher G., Sonnenblick M. Steroid-sparing medications in temporal arteritis - report of three cases and review of 174 reported patients. Clin. Rheumatol. 13:1994;289-292.
118. Noskov S.M. Megaloblastic pancytopenia in a female patient with rheumatoid arthritis given methotrexate and amidopyrine simultaneously. Megaloblasticheskaia pantsitopeniia u bol'noi revmatoidnym artritom pri odnovremennom primeneniem metotreksata i amidopirina Terapevticheskii Arkhiv. 62:1990;122-123.
119. O'Reilly S., Hartley P., Jeffers M., Casey E., Clancy L. Invasive pulmonary aspergillosis associated with low dose methotrexate therapy for rheumatoid arthritis: a case report of treatment with itraconazole. Tuberc. Lung Dis. 75:1994;153-155.
120. Padeh S., Sharon N., Schiby G., Rechavi G., Passwell J.H. Hodgkin's lymphoma in systemic onset juvenile rheumatoid arthritis after treatment with low dose methotrexate. J. Rheumatol. 24:1997;2035-2037.
121. Perruquet J.L., Harrington T.M., Davis D.E. Pneumocystis carinii pneumonia following methotrexate therapy for rheumatoid arthritis. Arthritis Rheum. 26:1983;1291-1292.
122. Phillips C.A., Cera P.J., Mangan T.F., Newman E.D. Clinical liver disease in patients with rheumatoid arthritis taking methotrexate. J. Rheumatol. 19:1992;229-233.
123. Porawska W. Overdose of methotrexate with a fatal outcome in a patient with rheumatoid arthritis. Przedawkowanie metotreksatu przyczyna zgonu chorej na reumatoidalne zapalenie stawow Polskie Archi. Med. Wewnet. 93:1995;346-350.
124. Raccaud O. Manifestations extra-articulaires de la polyarthrite rheumatoide lors d'un traitement de fond par methotrexate: a propos d'un cas de nodulose avec pericardite. Extra-articular manifestations of rheumatoid arthritis at the time of basic methotrexate treatment: apropos of a case of nodulosis with pericarditis Rev. Med. Suisse Rom. 114:1994;343-344.
125. Rau R., Schleusser B., Herborn G., Karger T. Long term treatment of destructive rheumatoid arthritis with methotrexate. J. Rheumatol. 24:1997;1881-1889.
126. Rich E., Moreland L.W., Alarcón G.S. Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease-modifying anti-rheumatic drug. J. Rheumatol. 26:1999;259-261.
127. Robinson J.K., Baughman R.D., Auerbach R., Cimis R.J. Methotrexate hepatotoxicity in psoriasis. Consideration of liver biopsies at regular intervals. Arch. Dermatol. 116:1980;413-415.
128. Rose C.D., Singsen B.H., Eichenfield A.H., Goldsmith D.P., Athreya B.H. Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritis. J. Pediatrics. 117:1990;653-659.
129. Rothenberg R.J., Graziano F.M., Grandone J.T., Goldberg J.W., Bjarnason D.F., Finesilver A.G. The use of methotrexate in steroid-resistant systemic lupus erythematosus. Arthritis Rheum. 31:1988;612-615.
130. Roux N., Flipo R.M., Cortet B., Lafitte J.J., Tonnel A.B., Duquesnoy B., Delcambre B. Pneumocystis carinii pneumonia in rheumatoid arthritis patients treated with methotrexate. A report of two cases. Revue Du Rhum. 63:1996;453-456.
131. Salloum E., Cooper D.L., Howe G., Lacy J., Tallini G., Crouch J., Schultz M., Murren J. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J. Clin. Oncol. 14:1996;1943-1949.
132. Sandoval D.M., Alarcón G.S., Morgan S.L. Adverse events in methotrexate-treated rheumatoid arthritis patients. Br. J. Rheumatol. 34:1995;49-56.
133. Sany J., Anaya J.M., Lussiez V., Couret M., Combe B., Daures J.P. Treatment of rheumatoid arthritis with methotrexate: a prospective open long term study of 191 cases. J. Rheumatol. 18:1991;1323-1327.
134. Schiff M., Kaine J., Strand V., Sharp J. X-ray analysis of 12 months treatment of active rheumatoid arthritis with leflunomide compared to placebo or methotrexate. Arthritis Rheum. 41:1998;S155.
135. Schnabel A., Herlyn K., Burchardi C., Reinhold-Keller E., Gross W.L. Long-term tolerability of methotrexate at doses exceeding 15 mg per week in rheumatoid arthritis. Rheumatol. Int. 15:1996;195-200.
136. Searles G., McKendry R.J.R. Methotrexate pneumonitis in rheumatoid arthritis: Potential risk factors. Four case reports and a review of the literature. J. Rheumatol. 14:1987;1164-1171.
137. Segal R., Caspi D., Tishler M., Fishel B., Yaron M. Accelerated nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis. Arthritis Rheum. 31:1988;1182-1185.
138. Seideman P., Muller-Suur R., Ekman E. Renal effects of low dose methotrexate in rheumatoid arthritis. J. Rheumatol. 20:1998;1126-1128.
139. Sharp J.T. Assessment of radiographic abnormalities in rheumatoid arthritis: what have we accomplished and where should we go from here? J. Rheumatol. 22:1995;1787-1791.
140. Shergy W.J., Polisson R.P., Caldwell D.S., Rice J.R., Pisetsky D.S., Allen N.B. Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis. Am. J. Med. 85:1988;711-774.
141. Shiroky J.B., Frost A., Skeleton J.D., Haegert D.G., Newkirk M.M., Neville C. Complications of immunosuppression associated with weekly low dose methotrexate. J. Rheumatol. 18:1991;1172-1175.
142. Singsen B.H., Goldbach-Mansky R. Methotrexate in the treatment of juvenile rheumatoid arthritis and other pediatric rheumatic and nonrheumatic disorders. Rheum. Dis. Clin. N. Am. 23:1997;811-841.
143. Situnayake R.D., Grindulis K.A., McConkey B. Long term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods. Ann. Rheum. Dis. 46:1987;177-183.
144. Sorensen W.T., Moller-Anderson K., Behrendt N. Rheumatoid nodules of the larynx. J. Laryngol. Otolol. 112:1998;573-574.
145. Stenger A.A., Houtman P.M., Bruyn G.A., Eggink H.F., Pasma H.R. Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis. Scand. J. Rheumatol. 23:1994;51-53.
146. Tanaka Y., Shiozawa K., Nishibayashi Y., Imura S. Methotrexate induced early onset pancytopenia in rheumatoid arthritis: drug allergy? Idiosyncrasy? J. Rheumatol. 19:1992;1320-1321.
147. Thevenet J.P., Ristori J.M., Cure H., Mizony M.H., Bussiere J.L. Pancytopenie au cours du traitement d'une polyarthrite rheumatoide par methotrexate apres administration de trimethoprime-sulfamethoxazole. Pancytopenia during treatment of rheumatoid arthritis with methotrexate after administration of trimethoprim-sulfamethoxazole Presse Medicale. 16:1987;1487.
148. Thomas M.H., Gutterman L.A. Methotrexate toxicity in a patient receiving trimethoprim-sulfamethoxazole. J. Rheumatol. 13:1986;440-441.
149. Thomas E., Leroux J.L., Hellier J.P., Blotman F. Seizure and methotrexate therapy in rheumatoid arthritis. J. Rheumatol. 20:1993;1632.
150. Toews G.B., Lynch J.P.I. Methotrexate in sarcoidosis. Am. J. Med. Sci. 300:1990;33-36.
151. Trenkwalder P., Eisenlohr H., Prechtel K., Lydtin H. Three cases of malignant neoplasm, pneumonitis, and pancytopenia during treatment with low-dose methotrexate. Clin. Invest. 70:1992;951-955.
152. van den Hoogen F.H.J., Boerbooms A.M.T., van de Putte L.B. Methotrexate treatment in scleroderma. Am. J. Med. 87:1989;116-117.
153. Van der Veen M.J., Dekker J.J., Dinant H.J., van Soesbegen R.M., Bijlsma J.W. Fatal pulmonary fibrosis complicating low dose methotrexate therapy for rheumatoid arthritis. J. Rheumatol. 22:1995;1766-1768.
154. Van der Veen M.J., van der Heide A., Kruize A.A., Bijisma J.W. Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate. Ann. Rheum. Dis. 53:1994;224-228.
155. Walker A.M., Funch D., Dreyer N.A., Tolman K.G., Kremer J.M., Alarcón G.S., Lee R.G., Weinblatt M.E. Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis. Arthritis Rheum. 36:1993;329-335.
156. Webster G.F., Razsi L.K., Sanchez M. Methotrexate therapy in cutaneous sarcoidosis. Ann. Int. Med. 111:1989;538-539.
157. Weinblatt M.E., Kaplan H., Germain B.F., Block S., Solomon S.D., Merriman R.C., Wolfe F., Wall B., Anderson L., Gall E., Torretti D., Weissman B. Methotrexate in rheumatoid arthritis: A five-year prospective multicenter study. Arthritis Rheum. 37:1994;1492-1498.
158. Weinblatt M.E., Polisson R., Blotner S.D., Sosman J.L., Aliabadi P., Baker N., Weissman B.N. The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin. Arthritis Rheum. 36:1993;613-619.
159. Weinblatt M.E., Weissman B.N., Holdsworth D.E., Fraser P.A., Maier A.L., Falchuk K.R., Coblyn J.S. Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update. Arthritis Rheum. 35:1992;129-137.
160. Wernick R., Smith D.L. Central nervous system toxicity associated with weekly low-dose methotrexate treatment. Arthritis Rheum. 32:1989;770-775.
161. White P., Ansell B.M. Methotrexate for juvenile rheumatoid arthritis. N. Engl. J. Med. 326:1992;1077-1078.
162. Wilke W.S., Krall P.L., Scheetz R.J., Babiak T., Danoa T., Mazanec D.J., Segal A.M., Clough J.D. Methotrexate for systemic lupus erythematosus: A retropective analysis of 17 unselected cases. Clin. Exp. Rheumatol. 9:1991;581-588.
163. Williams F.M., Cohen P.R., Arnett F.C. Accelerated cutaneous nodulosis during methotrexate therapy in a patient with rheumatoid arthritis. J. Am. Acad. Dermatol. 39:1998;359-362.
164. Winick N.J., Kamen B.A., Balis F.M. Folate and methotrexate polyglutamate tissue levels in Rhesus monkeys following chronic low-dose methotrexate. Cancer Drug Deliv. 4:1987;25-31.
165. Wolfe F. The epidemiology of drug treatment failure in rheumatoid arthritis. Baillieres Clin. Rheumatol. 9:1995;619-632.
166. Wolfe F., Hawley D.J., Cathey M.A. Termination of slow acting antirheumatic therapy in rheumatoid arthritis. A 14-year prospective evaluation of 1017 consecutive starts. J. Rheumatol. 17:1990;994-1002.
167. Worthley S.G., McNeil J.D. Leukoencephalopathy in a patient taking low dose oral methotrexate therapy for rheumatoid arthritis. J. Rheumatol. 22:1995;335-337.
168. Wyss E., Kuhn M., Luzi H.P., Reinhart W.H. Fatal verlaufende pneumocystis-carinii-pneumonie unter low-dose-methotrexat-und prednison-therapie wegen chronischer polyarthritis. Fatal outcome of pneumocystis-carinii pneumonia under low-dose methotrexate and prednisone therapy for chronic rheumatoid arthritis Schweiz. Rundsch. Med. Prax. 83:1994;449-452.
169. Zimmer-Galler I., Lie J.T. Choroidal infiltrates as the initial manifestation of lymphoma in rheumatoid arthritis after treatment with low-dose methotrexate. Mayo Clin. Proc. 69:1994;258-261.
170. Zonneveld I.M., Bakker W.K., Dijkstra P.F., Bos J.D., van Soesbergen R.M., Dinant H.J. Methotrexate osteopathy in long-term, low-dose methotrexate treatment for psoriasis and rheumatoid arthritis. Archives Dermatol. 132:1996;184-187.